Objectives: To investigate the possible effect of melatonin (MEL) and zinc on the immune response to Toxoplasma gondii retinochoroiditis in the rat model of infection and to establish the possible value of artificial MEL and/or zinc supplementation as adjunctive therapeutic agents in the treatment of T. gondii retinochoroiditis. Methods: Eighty-four Sprague-Dawley male rats were divided into 12 equal groups. All groups, except controls were infected with T. gondii parasite by intraperitoneal injection. Combinations of zinc-deficient diet, pinealectomy (Px), and artificial zinc and MEL were supplied during a 1-month period. At the end of the experiment, retinal and choroidal total lymphocytes, CD3+, CD4+, and CD8+ cell numbers were counted in histological sections. Results: The highest amount of cellular infiltration (lymphocytes, CD3+, CD4+, CD8+ cells) in the choroid and retina was detected in infected + MEL + zinc-treated rats, and the least amount of cellular infiltration was observed in Px + zinc-deficient diet-treated rats. Although single zinc or MEL supplementation had no significant impact on the cellular infiltration in the retina and choroid in Px rats, combined therapy significantly improved these responses. Conclusion: Artificial supplementation of MEL and zinc should be considered as an adjunctive therapy to classic treatment of Toxoplasma retinochoroiditis especially in immunosuppressed and elderly patients if our data are confirmed in a clinical setting.

Keywords:
Toxoplasma gondii retinochoroiditis, Zinc, Melatonin, Pinealectomy
1.
Tabbara KF: Management of ocular toxoplasmosis. Trans Pacific Coast Ophthalmol Soc 1983;63:23–35.
2.
Hakim FT, Gazzinelli RT, Denkers E, et al: CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite infected or antigen pulsed host cells. J Immunol 1991;147:2310–2316.
3.
Subauste CS, Koniaris AH, Remington JS: Murine CD8+ cytotoxic T-lymphocytes lyse Toxoplasma gondii infected cells. J Immunol 1991;147:3955–3959.
4.
Velimirovic B: Toxoplasmosis in immunosuppression and AIDS. Infection 1984;12:315–317.
5.
Levy RM, Bredesen DE: Central nervous system dysfunction in acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr 1988;1:41–64.
6.
Mocchegiani E, Giacconi R, Muzzioli M, et al: Zinc, infections and immunosenescence. Mech Ageing Dev 2001;121:21–35.
7.
Pawelec G, Solana R: Immunosenescence. Immunol Today 1997;18:514–516.
8.
Hadden JW: Thymic endocrinology. Ann N Y Acad Sci. 1998;1:352–358.
9.
Prasad AS: Zinc and immunity. Mol Cell Biochem. 1998;188:63–69.
10.
Prasad AS, Beck FWJ, Kaplan J, et al: Effect of zinc supplementation on incidence of infections and hospital admissions in sickle cell disease. Am J Hematol 1999;61:194–202.
11.
Maestroni GJ: The immunoneuroendocrine role of melatonin. J Pineal Res 1993;14:1–10.
12.
Mocchegiani E, Santarelli L, Tibaldi A, et al: Presence of links between zinc and melatonin during circadian cycle in old mice: effects on thymic endocrine activity and on survival. J Neuroimmunol 1998;86:111–112.
13.
Mocchegiani E, Perisin L, Santarelli L, et al: Melatonin administration in tumor-bearing mice (intact and pinealectomized) in relation to stress, zinc, thymulin, and IL 2. Int J Immunopharmacol 1999;21:27–46.
14.
Skwarlo-Sonta SK: Functional connections between the pineal gland and immune system. Acta Neurobiol Exp 1996;56:341–357.
15.
del Gobbo V, Libri V, Villani N, et al: Pinealectomy inhibits interleukin-2 and natural killer activity in mice. Int J Immunopharmacol 1989;11:567–573.
16.
Mocchegiani E, Bullian L, Santarelli L, et al: The immune-reconstituting effect of melatonin or pineal grafting and its relation to zinc pool in aging mice. J Neuroimmunol 1994;53:189–201.
17.
Mocchegiani E, Bullian L, Santarelli L, et al: The zinc pool is involved in the immune-reconstituting effect of melatonin in pinealectomized mice. J Pharmacol Exp Ther 1996;277:1200–1208.
18.
Kuszak J, Rodin MA: New technique of pinealectomy for adult rats. Pro Experimentis 1977;33:283–284.
19.
Pavesio CE, Chiappino ML, Gormley P, Setser PY, Nicholls PA: Acquired retinochoroiditis in hamsters inoculated with ME 49 strain Toxoplasma. Invest Ophthalmol Vis Sci 1995;36:2166–2175.
20.
Gormley PD, Pavesio CE, Luthert P, Lightman S: Retinochoroiditis is induced by oral administration of Toxoplasma gondii cysts in the hamster model. Exp Eye Res 1999;68:657–661.
21.
Elwell MR, Frenkel JK: Acute toxoplasmosis in hamsters and mice: measurement of pathogenicity by fever and weight loss. Am J Vet Res 1984;45:2663–2667.
22.
Denkers EY, Sher A, Gazzinelli RT: CD8+ T-cell interactions with T. gondii: implications for processing of antigen for class-I-restricted recognition. Res Immunol 1993;144:51–57.
23.
Innes EA, Panton WR, Sanderson A, Thomson KM, Wastling JM, Maley S, Buxton D: Induction of CD4+ and CD8+ T cell responses in efferent lymph responding to Toxoplasma gondii infection: analysis of phenotype and function. Parasitol Immunol 1995;17:151–160.
24.
Khan IA, Ely KH, Kasper LH: A purified parasite antigen (p30) mediates CD8+ T cell immunity against fatal T. gondii infection in mice. J Immunol 1991;147:3501–3506.
25.
Gazzinelli RT, Hakim FT, Hieny S, Shearer GM, Sher A: Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-γ production and protective immunity induced by an attenuated T. gondii vaccine. J Immunol 1991;146:286–292.
26.
Herion P, Saavedra R: Human T-cell clones as tools for the characterization of the cell mediated immune response to Toxoplasma gondii. Res Immunol 1993;144:48–51.
27.
Brown CR, McLeod R: Class IMHC genes and CD8+ T cells determine cyst number in Toxoplasma infection. J Immunol 1990;145:3438–3441.
28.
Hu MS, Schwartzman JD, Yeaman GR, Collins J, Seugin R, Khan IA, Kasper LH: Fas FasL interaction involved in pathogenesis of ocular toxoplasmosis in mice. Infect Immun 1999;67:928–935.
29.
Reiter RJ, Calvo JR, Karbownik M, Qi W, Tan DX: Melatonin and its relation to the immune system and inflammation. Ann N Y Acad Sci. 2000;917:376–386.
30.
Haldar C, Singh R: Seasonal changes in melatonin and immunological adaptation in birds. J Endocrinol Reprod 2001;5:13–24.
31.
Guerrero JM, Reiter RJ: A brief survey of pineal gland-immune system interrelationship. Endocrinol Res 1992;18:91–113.
32.
Riddle O: Sex and seasonal differences in weight of liver and spleen. Proc Soc Exp Biol Med 1928;25:474–476.
33.
Rai S, Haldar C: Pineal control of immune status and hematological changes in blood and bone marrow of male squirrels (Funambulus pennati) during their reproductively active phase. Comparative Biochemistry and Physiology. Toxicol Pharmacol 2003;136:319–328.
34.
Maestroni GJ: Therapeutic potential of melatonin in immunodeficiency states, viral diseases, and cancer. Adv Exp Med Biol 1999;467:217–226.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.